European Pharmaceutical Manufacturer is a highly regarded publication covering the pharma/biopharma manufacturing supply chain from formulation to distribution, keeping readers informed of the latest news, opinions, developments and breakthroughs in this innovative and technologically advanced sector. The bi-monthly publication reaches over 18,000 readers, including decision makers and opinion leaders in the European pharma manufacturing industry
Drug delivery devices for self-administration must go through compulsory human factors (HF) studies before reaching the market, to help identify and eliminate any risks the device may present to the end user.
To find out more about the study, please view the full article on page 29.